Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Gilead Sciences Could Gain 30%
Barron's
Friday, September 19, 2014 - 2:18pm
tags:
Gilead Sciences, SOF/LDV, hepatitis C
3 Companies To Profit From This Medical Boom
Yahoo/StreetAuthority
Friday, September 19, 2014 - 2:11pm
tags:
robotics, Varian Medical, Stryker, Intuitive Surgical, devices
How Will GlaxoSmithKline (GSK) Stock Be Affected By This Lawsuit?
TheStreet.com
Friday, September 19, 2014 - 2:09pm
tags:
GSK, China
Pfizer Provides $2M to Support ‘Last-Mile’ Vaccine Coverage
Drug Discovery and Development
Friday, September 19, 2014 - 10:50am
tags:
Pfizer, Africa, vaccines
Lilly's Cyramza shows survival benefit in gastro cancers
Pharma Times
Friday, September 19, 2014 - 9:53am
tags:
Eli Lilly, Cyramza, gastric cancer
Still feeling the Vioxx pain
Pharmaceutical Journal
Friday, September 19, 2014 - 9:48am
tags:
Vioxx
FDA to Test out New Standardized Medical Device Labels in Proposed Study
RAPS.org
Friday, September 19, 2014 - 9:42am
tags:
FDA, devices, labeling
Eli Lilly And The $58 Billion Diabetes Market
Bidness Etc.
Friday, September 19, 2014 - 9:39am
tags:
Eli Lilly, diabetes, Trulicity
White House calls for task force to tackle antibiotic-resistant bugs
Yahoo/Reuters
Friday, September 19, 2014 - 9:22am
tags:
antibiotics, antibiotic resistance
FDA advisers shoot down Clarus' pitch for a new low-T drug
Fierce Biotech
Friday, September 19, 2014 - 8:58am
tags:
FDA, Clarus Therapeutics, advisory panels, Rextoro, testosterone
Merck Serono pledges €150m to biosimilars in 2015
Bio-Pharma Reporter
Friday, September 19, 2014 - 8:54am
tags:
Merck Serono, R&D, biosimilars
Pfizer eyes Parkinson’s disease treatments with MedGenesis pact
Bio-Pharma Reporter
Friday, September 19, 2014 - 8:52am
tags:
Pfizer, MedGenesis, Parkinson's Disease
OncoGenex's Phase III Prostate Cancer Study Fully Enrolled
Yahoo/Zacks.com
Friday, September 19, 2014 - 8:51am
tags:
OncoGenex, prostate cancer, Jevtana
GSK China guilty of bribery
Pharmaphorum
Friday, September 19, 2014 - 8:49am
tags:
GSK, China, bribery
Valeant’s Improving Stock Price Makes Its Allergan Bid Look Better
WSJ Online
Thursday, September 18, 2014 - 7:39pm
tags:
Allergan, Valeant Pharmaceuticals, M&A
Impax Rytary FDA Action Date Extended by Three Months
Yahoo/Zacks.com
Thursday, September 18, 2014 - 7:37pm
tags:
Impax, Rytary, FDA, IPX066
Bayer Deal for Zoetis in Sight After Unit Sale: Real M&A
Bloomberg
Thursday, September 18, 2014 - 7:30pm
tags:
Bayer, Zoetis, animal health
FDA Approves Lilly's Once-Weekly Shot For Diabetes
Forbes
Thursday, September 18, 2014 - 7:28pm
tags:
FDA, Eli Lilly, diabetes, Trulicity, dulaglutide
Gilead Sciences: Failed Trial Always a ‘Long Shot’
Barron's
Thursday, September 18, 2014 - 12:03pm
tags:
Gilead Sciences, clinical trials, pancreatic cancer, simtuzumab
Dealpolitik: Allergan Fight Could Extend Long Past December Meeting
WSJ Online
Thursday, September 18, 2014 - 10:29am
tags:
Allergan, Valeant Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.